ADAR Mediated RNA Editing Modulates Microrna Targeting in Human Breast Cancer

Total Page:16

File Type:pdf, Size:1020Kb

ADAR Mediated RNA Editing Modulates Microrna Targeting in Human Breast Cancer processes Article ADAR Mediated RNA Editing Modulates MicroRNA Targeting in Human Breast Cancer Justin T. Roberts 1 ID , Dillon G. Patterson 1, Valeria M. King 1, Shivam V. Amin 1, Caroline J. Polska 1, Dominika Houserova 2, Aline Crucello 1, Emmaline C. Barnhill 1, Molly M. Miller 1, Timothy D. Sherman 1 and Glen M. Borchert 1,2,* ID 1 Department of Biology, University of South Alabama, Mobile, AL 36688-0002, USA; [email protected] (J.T.R.); [email protected] (D.G.P.); [email protected] (V.M.K.); [email protected] (S.V.A.); [email protected] (C.J.P.); [email protected] (A.C.); [email protected] (E.C.B.); [email protected] (M.M.M.); [email protected] (T.D.S.) 2 Department of Pharmacology, USA College of Medicine, Mobile, AL 36688-0002, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-251-460-7310 Received: 6 April 2018; Accepted: 21 April 2018; Published: 25 April 2018 Abstract: RNA editing by RNA specific adenosine deaminase acting on RNA (ADAR) is increasingly being found to alter microRNA (miRNA) regulation. Editing of miRNA transcripts can affect their processing, as well as which messenger RNAs (mRNAs) they target. Further, editing of target mRNAs can also affect their complementarity to miRNAs. Notably, ADAR editing is often increased in malignancy with the effect of these RNA changes being largely unclear. In addition, numerous reports have now identified an array of miRNAs that directly contribute to various malignancies although the majority of their targets remain largely undefined. Here we propose that modulating the targets of miRNAs via mRNA editing is a frequent occurrence in cancer and an underappreciated participant in pathology. In order to more accurately characterize the relationship between these two regulatory processes, this study examined RNA editing events within mRNA sequences of two breast cancer cell lines (MCF-7 and MDA-MB-231) and determined whether or not these edits could modulate miRNA associations. Computational analyses of RNA-Seq data from these two cell lines identified over 50,000 recurrent editing sites within human mRNAs, and many of these were located in 30 untranslated regions (UTRs). When these locations were screened against the list of currently-annotated miRNAs we discovered that editing caused a subset (~9%) to have significant alterations to mRNA complementarity. One miRNA in particular, miR-140-3p, is known to be misexpressed in many breast cancers, and we found that mRNA editing allowed this miRNA to directly target the apoptosis inducing gene DFFA in MCF-7, but not in MDA-MB-231 cells. As these two cell lines are known to have distinct characteristics in terms of morphology, invasiveness and physiological responses, we hypothesized that the differential RNA editing of DFFA in these two cell lines could contribute to their phenotypic differences. Indeed, we confirmed through western blotting that inhibiting miR-140-3p increases expression of the DFFA protein product in MCF-7, but not MDA-MB-231, and further that inhibition of miR-140-3p also increases cellular growth in MCF-7, but not MDA-MB-231. Broadly, these results suggest that the creation of miRNA targets may be an underappreciated function of ADAR and may help further elucidate the role of RNA editing in tumor pathogenicity. Keywords: ADAR; breast; cancer; inosine; microRNA; microRNA targeting; RNA editing Processes 2018, 6, 42; doi:10.3390/pr6050042 www.mdpi.com/journal/processes Processes 2018, 6, 42 2 of 14 Processes 2018, 6, x FOR PEER REVIEW 2 of 14 1.1. Introduction TranscriptTranscript variationvariation atat thethe singlesingle nucleotidenucleotide levellevel isis increasingly being foundfound to have widespread occurrencesoccurrences withinwithin thethe transcriptometranscriptome withwith fundamentalfundamental roles inin numerousnumerous biologicalbiological processesprocesses includingincluding developmentdevelopment andand disease.disease. Specifically, Specifically, several independent studies have reported thatthat therethere areare hundredshundreds ofof thousandsthousands ofof RNARNA editingediting sitessites catalyzedcatalyzed byby thethe enzymeenzyme ADARADAR (adenosine(adenosine deaminasedeaminase actingacting onon RNA)RNA) withinwithin humanhuman mRNAsmRNAs [[11––66].]. EditingEditing viavia ADARADAR isis characterizedcharacterized byby thethe conversionconversion ofof thethe nucleic acid adenosine to inosine via deamination at the C6 position [7] [7] (Fig (Figureure 11).). SinceSince inosinesinosines havehave been shown to preferentially bind to cytosines, functionally the ADAR-catalyzedADAR-catalyzed editingediting changeschanges an ‘A’‘A’ toto aa ‘G’‘G’ inin thethe transcripttranscript sequencesequence [[7]7].. Interestingly,Interestingly, thethe vastvast majoritymajority (>99%)(>99%) ofof editingediting sitessites occuroccur inin thethe UTRsUTRs ofof primate-specificprimate-specific AluAlu elementselements [[88––1010],], likelylikely duedue toto thethe commoncommon occurrenceoccurrence ofof two two oppositely oppositely oriented oriented Alus Alus located located in the in same the pre-mRNAsame pre-mRNA pairing pairing together together to produce to theproduce long andthe stablelong and double-stranded stable double- RNAstranded structure RNA thatstructure is required that is for required ADAR for to bind.ADAR As to the bind. ability As tothe convert ability nucleotidesto convert nucleotides adds a great adds deal a ofgreat functionality deal of functionality to the transcriptome, to the transcriptome, it is not surprising it is not thatsurprising it has fundamentalthat it has fundamental roles in many roles cellular in many activities. cellular Editing activities. events Editing within events mRNA within coding mRNA for variouscoding for neuroreceptors, various neuroreceptors such as serotonin, such as and serotonin glutamate, and have glutamate been intensively, have been detailed intensively in an detailed array of organismsin an array from of organisms flatworms from to primates flatworms and to found primates to be criticaland found for routine to be criti neuralcal for activity routine [11 ].neural With regardsactivity to[11] gene. With regulation, regards to sequence gene regulation, editing ofsequence RNA has editing widespread of RNA implications, has widespread including implications splice, siteincluding alteration, splice localization site alteration, and nuclear localization retention, and andnuclear modification retention, to and the RNAmodification secondary to structurethe RNA itselfsecondary [12]. Further, structure given itself these [12] abundant. Further, roles given for these ADAR abundant editing inroles routine for cellularADAR function,editing in it routine should alsocellular not befunction, surprising it should that dysfunction also not be ofsurprising this important that dysfunction mechanism of can this have important detrimental mechanism effects and,can indeed,have detrimental an increasing effects number and, ofindeed reports, an indicate increasing a strong number correlation of reports between indicate altered a strong ADAR correlation activity andbetween a variety altered of pathologies. ADAR activity Specifically, and a variety because of ADARpathologies. has been Specifically, shown to bebecause such an ADAR integral has player been inshown apoptotic to be regulationsuch an integral and cellular player differentiation, in apoptotic regulation cancer is ofand especially cellular heighteneddifferentiation, interest cancer and, is inof fact,especially more andheightened more evidence interest isand pointing, in fact to, more dysregulation and more of evidence the editing is pointing process beingto dysregul a majoration factor of inthe tumorigenesis editing process [13 being–18]. a major factor in tumorigenesis [13–18]. FigureFigure 1.1. ADARs deaminate deaminate adenosine adenosine to to inosine, inosine, potentially potentially altering altering miRNA miRNA complementarities complementarities.. A Acartoon cartoon depicting depicting adenosine adenosine (left (left), ),deaminated deaminated adenosine adenosine (inosine, (inosine, in in centercenter), ),and and guanine guanine (right (right). ). EditingEditing eventsevents can can also also have have widespread widespread effects effects on theon genethe gene regulatory regulatory ability ability of noncoding of noncoding RNAs, suchRNAs as, miRNAssuch as miRNAs [17,19]. MiRNAs [17,19]. areMiRNAs small regulatoryare small RNAregulatory molecules RNA roughly molecules 20 to roughly 23 nucleotides 20 to 23 in lengthnucleotides that regulatein length cell that processes regulate by cell binding processes to their by binding target mRNAs to their andtarget inhibiting mRNAs translation and inhibiting [20]. MiRNAstranslation are [20]. initially MiRNAs transcribed are initially as primary transcribed miRNAs as primary (pri-miRNAs) miRNAs consisting (pri-miRNAs) of several consisting thousand of nucleotidesseveral thousand in length nucleotides that are thenin length processed that are by intothen matureprocessed miRNAs by into by mature the enzymes miRNAs Dicer by andthe Droshaenzymes before Dicer enteringand Dros theha RNAibefore gene entering silencing the RNAi complex gene where silencing they complex regulate where gene expressionthey regulate by bindinggene expression to the 30 byUTR binding of their to mRNAthe 3′ UTR targets of their via complimentarymRNA targets via base complimentary
Recommended publications
  • DFFA Monoclonal Antibody (M05), Degradation of the Chromosomal DNA Into Nucleosomal Clone 3A11 Units
    DFFA monoclonal antibody (M05), degradation of the chromosomal DNA into nucleosomal clone 3A11 units. DNA fragmentation factor (DFF) is a heterodimeric protein of 40-kD (DFFB) and 45-kD (DFFA) subunits. Catalog Number: H00001676-M05 DFFA is the substrate for caspase-3 and triggers DNA fragmentation during apoptosis. DFF becomes activated Regulatory Status: For research use only (RUO) when DFFA is cleaved by caspase-3. The cleaved fragments of DFFA dissociate from DFFB, the active Product Description: Mouse monoclonal antibody component of DFF. DFFB has been found to trigger both raised against a partial recombinant DFFA. DNA fragmentation and chromatin condensation during apoptosis. Two alternatively spliced transcript variants Clone Name: 3A11 encoding distinct isoforms have been found for this gene. [provided by RefSeq] Immunogen: DFFA (NP_004392.1, 231 a.a. ~ 331 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. Sequence: TSSDVALASHILTALREKQAPELSLSSQDLELVTKEDPK ALAVALNWDIKKTETVQEACERELALRLQQTQSLHSLR SISASKASPPGDLQNPKRARQDPT Host: Mouse Reactivity: Human Applications: ELISA, PLA-Ce, S-ELISA, WB-Re, WB-Tr (See our web site product page for detailed applications information) Protocols: See our web site at http://www.abnova.com/support/protocols.asp or product page for detailed protocols Isotype: IgG2a Kappa Storage Buffer: In 1x PBS, pH 7.4 Storage Instruction: Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. Entrez GeneID: 1676 Gene Symbol: DFFA Gene Alias: DFF-45, DFF1, ICAD Gene Summary: Apoptosis is a cell death process that removes toxic and/or useless cells during mammalian development. The apoptotic process is accompanied by shrinkage and fragmentation of the cells and nuclei and Page 1/1 Powered by TCPDF (www.tcpdf.org).
    [Show full text]
  • DFFB (NM 004402) Human Tagged ORF Clone Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC208266 DFFB (NM_004402) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: DFFB (NM_004402) Human Tagged ORF Clone Tag: Myc-DDK Symbol: DFFB Synonyms: CAD; CPAN; DFF-40; DFF2; DFF40 Vector: pCMV6-Entry (PS100001) E. coli Selection: Kanamycin (25 ug/mL) Cell Selection: Neomycin ORF Nucleotide >RC208266 ORF sequence Sequence: Red=Cloning site Blue=ORF Green=Tags(s) TTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTGGATCCGGTACCGAGGAGATCTGCC GCCGCGATCGCC ATGCTCCAGAAGCCCAAGAGCGTGAAGCTGCGGGCCCTGCGCAGCCCGAGGAAGTTCGGCGTGGCTGGCC GGAGCTGCCAGGAGGTGCTGCGCAAGGGCTGTCTCCGCTTCCAGCTCCCTGAGCGCGGTTCCCGGCTGTG CCTGTACGAGGATGGCACGGAGCTGACGGAAGATTACTTCCCCAGTGTTCCCGACAACGCCGAGCTGGTG CTGCTCACCTTGGGCCAGGCCTGGCAGGGCTATGTGAGCGACATCAGGCGCTTCCTCAGTGCATTTCACG AGCCACAGGTGGGGCTCATCCAGGCCGCCCAGCAGCTGCTGTGTGATGAGCAGGCCCCACAGAGGCAGAG GCTGCTGGCTGACCTCCTGCACAACGTCAGCCAGAACATCGCGGCCGAGACCCGGGCTGAGGACCCGCCG TGGTTTGAAGGCTTGGAGTCCCGATTTCAGAGCAAGTCTGGCTATCTGAGATACAGCTGTGAGAGCCGGA TCCGGAGTTACCTGAGGGAGGTGAGCTCCTACCCCTCCACAGTGGGTGCGGAGGCTCAGGAGGAATTCCT GCGGGTCCTCGGCTCCATGTGCCAGAGGCTCCGGTCCATGCAGTACAATGGCAGCTACTTCGACAGAGGA GCCAAGGGCGGCAGCCGCCTCTGCACACCGGAAGGCTGGTTCTCCTGCCAGGGTCCCTTTGACATGGACA GCTGCTTATCAAGACACTCCATCAACCCCTACAGTAACAGGGAGAGCAGGATCCTCTTCAGCACCTGGAA CCTGGATCACATAATAGAAAAGAAACGCACCATCATTCCTACACTGGTGGAAGCAATTAAGGAACAAGAT GGAAGAGAAGTGGACTGGGAGTATTTTTATGGCCTGCTTTTTACCTCAGAGAACCTAAAACTAGTGCACA
    [Show full text]
  • ICAD Antibody Cat
    ICAD Antibody Cat. No.: 2003 ICAD Antibody Immunofluorescence of ICAD in mouse kidney tissue with ICAD antibody at 5 μg/ml. Immunohistochemistry of ICAD in mouse kidney tissue with ICAD antibody at 5 μg/ml. Green: ICAD antibody (2003) Red: Phylloidin staining Blue: DAPI staining Specifications HOST SPECIES: Rabbit SPECIES REACTIVITY: Mouse ICAD antibody was raised against a 20 amino acid peptide near the carboxy terminus of mouse ICAD. IMMUNOGEN: The immunogen is located within the last 50 amino acids of ICAD. TESTED APPLICATIONS: ELISA, IF, IHC-P, WB September 28, 2021 1 https://www.prosci-inc.com/icad-antibody-2003.html ICAD antibody can be used for detection of of ICAD by Western blot at 1:1000 dilution. A 45 kDa band can be detected. Antibody can also be used for immunohistochemistry starting at 5 μg/mL. For immunofluorescence start at 5 μg/mL. APPLICATIONS: Antibody validated: Western Blot in mouse samples; Immunohistochemistry in mouse samples and Immunofluorescence in mouse samples. All other applications and species not yet tested. POSITIVE CONTROL: 1) Cat. No. 1402 - Mouse Lung Tissue Lysate PREDICTED MOLECULAR 45 kDa WEIGHT: Properties PURIFICATION: ICAD Antibody is affinity chromatography purified via peptide column. CLONALITY: Polyclonal ISOTYPE: IgG CONJUGATE: Unconjugated PHYSICAL STATE: Liquid BUFFER: ICAD Antibody is supplied in PBS containing 0.02% sodium azide. CONCENTRATION: 1 mg/ml ICAD antibody can be stored at 4˚C for three months and -20˚C, stable for up to one year. STORAGE CONDITIONS: As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
    [Show full text]
  • Proteomic Analysis of Ubiquitin Ligase KEAP1 Reveals Associated Proteins That Inhibit NRF2 Ubiquitination
    Published OnlineFirst February 4, 2013; DOI: 10.1158/0008-5472.CAN-12-4400 Cancer Molecular and Cellular Pathobiology Research Proteomic Analysis of Ubiquitin Ligase KEAP1 Reveals Associated Proteins That Inhibit NRF2 Ubiquitination Bridgid E. Hast1, Dennis Goldfarb2, Kathleen M. Mulvaney1, Michael A. Hast4, Priscila F. Siesser1, Feng Yan1, D. Neil Hayes3, and Michael B. Major1,2 Abstract Somatic mutations in the KEAP1 ubiquitin ligase or its substrate NRF2 (NFE2L2) commonly occur in human cancer, resulting in constitutive NRF2-mediated transcription of cytoprotective genes. However, many tumors display high NRF2 activity in the absence of mutation, supporting the hypothesis that alternative mechanisms of pathway activation exist. Previously, we and others discovered that via a competitive binding mechanism, the proteins WTX (AMER1), PALB2, and SQSTM1 bind KEAP1 to activate NRF2. Proteomic analysis of the KEAP1 protein interaction network revealed a significant enrichment of associated proteins containing an ETGE amino acid motif, which matches the KEAP1 interaction motif found in NRF2. Like WTX, PALB2, and SQSTM1, we found that the dipeptidyl peptidase 3 (DPP3) protein binds KEAP1 via an "ETGE" motif to displace NRF2, thus inhibiting NRF2 ubiquitination and driving NRF2-dependent transcription. Comparing the spectrum of KEAP1-interacting proteins with the genomic profile of 178 squamous cell lung carcinomas characterized by The Cancer Genome Atlas revealed amplification and mRNA overexpression of the DPP3 gene in tumors with high NRF2 activity but lacking NRF2 stabilizing mutations. We further show that tumor-derived mutations in KEAP1 are hypomorphic with respect to NRF2 inhibition and that DPP3 overexpression in the presence of these mutants further promotes NRF2 activation.
    [Show full text]
  • Produktinformation
    Produktinformation Diagnostik & molekulare Diagnostik Laborgeräte & Service Zellkultur & Verbrauchsmaterial Forschungsprodukte & Biochemikalien Weitere Information auf den folgenden Seiten! See the following pages for more information! Lieferung & Zahlungsart Lieferung: frei Haus Bestellung auf Rechnung SZABO-SCANDIC Lieferung: € 10,- HandelsgmbH & Co KG Erstbestellung Vorauskassa Quellenstraße 110, A-1100 Wien T. +43(0)1 489 3961-0 Zuschläge F. +43(0)1 489 3961-7 [email protected] • Mindermengenzuschlag www.szabo-scandic.com • Trockeneiszuschlag • Gefahrgutzuschlag linkedin.com/company/szaboscandic • Expressversand facebook.com/szaboscandic DFFA Recombinant Protein (OPCD02721) Data Sheet Product Number OPCD02721 Product Page http://www.avivasysbio.com/dffa-recombinant-protein-opcd02721.html Product Name DFFA Recombinant Protein (OPCD02721) Size 10 ug Gene Symbol DFFA Alias Symbols A330085O09Rik, DFF35, Dff45, DFF-45, DNA fragmentation factor 45 kDa subunit, DNA fragmentation factor subunit alpha, Icad, ICAD, ICAD-L, IC AD-S, Inhibitor of CAD Molecular Weight 31 kDa Product Format Lyophilized Tag N-terminal His Tag Conjugation Unconjugated NCBI Gene Id 13347 Host E.coli Purity > 95% Source Prokaryotic Expressed Recombinant Official Gene Full Name DNA fragmentation factor, alpha subunit Description of Target Inhibitor of the caspase-activated DNase (DFF40). Reconstitution and Storage Reconstitute in PBS or others. Store at 2-8C for one month. Aliquot and store at -80C for 12 months. Avoid repeated freeze/thaw cycles. Additional Information Endotoxin Level: < 1.0 EU per 1 ug (determined by the LAL method) Additional Information Residues: Lys19 - Ser262 Lead Time Domestic: within 1-2 weeks delivery International: 1-3 weeks Formulation Lyophilized in PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
    [Show full text]
  • Anti-ICAD Antibody (ARG54401)
    Product datasheet [email protected] ARG54401 Package: 50 μg anti-ICAD antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes ICAD Tested Reactivity Hu Tested Application ICC/IF, WB Specificity This antibody recognizes non-cleaved (45kDa) and cleaved DFF45. Host Rabbit Clonality Polyclonal Isotype IgG Target Name ICAD Antigen Species Human Immunogen Peptide corresponding to aa 313-331 at the C-terminus of human DFF45 (accession no. NP_004392). Conjugation Un-conjugated Alternate Names DFF-45; DNA fragmentation factor 45 kDa subunit; Inhibitor of CAD; ICAD; DFF1; DNA fragmentation factor subunit alpha Application Instructions Application table Application Dilution ICC/IF Assay-dependent WB Assay-dependent Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Positive Control HeLa, Jurkat, A431 and K562 Calculated Mw 37 kDa Properties Form Liquid Purification Immunoaffinity chroma-tography Buffer PBS (pH 7.4) and 0.02% Sodium azide Preservative 0.02% Sodium azide Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. www.arigobio.com 1/2 Note For laboratory research only, not for drug, diagnostic or other use. Bioinformation Database links GeneID: 1676 Human Swiss-port # O00273 Human Gene Symbol DFFA Gene Full Name DNA fragmentation factor, 45kDa, alpha polypeptide Background A human DNA fragmentation factor (DFF) which is cleaved by caspase-3 during apoptosis was identified recently.
    [Show full text]
  • DFFA Antibody Cat
    DFFA Antibody Cat. No.: 27-308 DFFA Antibody Specifications HOST SPECIES: Rabbit SPECIES REACTIVITY: Human Antibody produced in rabbits immunized with a synthetic peptide corresponding a region IMMUNOGEN: of human DFFA. TESTED APPLICATIONS: ELISA, WB DFFA antibody can be used for detection of DFFA by ELISA at 1:312500. DFFA antibody can APPLICATIONS: be used for detection of DFFA by western blot at 5.0 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50,000 - 100,000. POSITIVE CONTROL: 1) Cat. No. 1205 - Jurkat Cell Lysate PREDICTED MOLECULAR 37 kDa, 29 kDa WEIGHT: Properties PURIFICATION: Antibody is purified by protein A chromatography method. CLONALITY: Polyclonal CONJUGATE: Unconjugated PHYSICAL STATE: Liquid September 29, 2021 1 https://www.prosci-inc.com/dffa-antibody-27-308.html Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% BUFFER: sucrose. CONCENTRATION: batch dependent For short periods of storage (days) store at 4˚C. For longer periods of storage, store DFFA STORAGE CONDITIONS: antibody at -20˚C. As with any antibody avoid repeat freeze-thaw cycles. Additional Info OFFICIAL SYMBOL: DFFA ALTERNATE NAMES: DFFA, DFF-45, DFF1, Ion ChannelAD, ICAD ACCESSION NO.: NP_004392 PROTEIN GI NO.: 4758148 GENE ID: 1676 USER NOTE: Optimal dilutions for each application to be determined by the researcher. Background and References Apoptosis is a cell death process that removes toxic and/or useless cells during mammalian development. The apoptotic process is accompanied by shrinkage and fragmentation of the cells and nuclei and degradation of the chromosomal DNA into nucleosomal units. DNA fragmentation factor (DFF) is a heterodimeric protein of 40-kD (DFFB) and 45-kD (DFFA) subunits.
    [Show full text]
  • Primepcr™Assay Validation Report
    PrimePCR™Assay Validation Report Gene Information Gene Name DNA fragmentation factor, 45kDa, alpha polypeptide Gene Symbol DFFA Organism Human Gene Summary Apoptosis is a cell death process that removes toxic and/or useless cells during mammalian development. The apoptotic process is accompanied by shrinkage and fragmentation of the cells and nuclei and degradation of the chromosomal DNA into nucleosomal units. DNA fragmentation factor (DFF) is a heterodimeric protein of 40-kD (DFFB) and 45-kD (DFFA) subunits. DFFA is the substrate for caspase-3 and triggers DNA fragmentation during apoptosis. DFF becomes activated when DFFA is cleaved by caspase-3. The cleaved fragments of DFFA dissociate from DFFB the active component of DFF. DFFB has been found to trigger both DNA fragmentation and chromatin condensation during apoptosis. Two alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. Gene Aliases DFF-45, DFF1, ICAD RefSeq Accession No. NC_000001.10, NG_008340.1, NT_021937.19 UniGene ID Hs.484782 Ensembl Gene ID ENSG00000160049 Entrez Gene ID 1676 Assay Information Unique Assay ID qHsaCID0012769 Assay Type SYBR® Green Detected Coding Transcript(s) ENST00000377038, ENST00000377036 Amplicon Context Sequence CTGGCCACATTCTTCCACTTCAACCCTGCCCCGCTGTCTGTTTCATCTACATCAA AGGACTCTTGGGAAATCCAAGCTGTACCTCCATCTGAATTGTTGTATGCCCATTT CTCATTACTAGCCAATGCCACAAACTTAGTATTGGAAGGTAGACACA Amplicon Length (bp) 127 Chromosome Location 1:10527302-10529302 Assay Design Intron-spanning Purification Desalted Validation Results
    [Show full text]
  • DFFA Conjugated Antibody
    Product Datasheet DFFA Conjugated Antibody Catalog No: #C27370 Package Size: #C27370-AF350 100ul #C27370-AF405 100ul #C27370-AF488 100ul Orders: [email protected] Support: [email protected] #C27370-AF555 100ul #C27370-AF594 100ul #C27370-AF647 100ul #C27370-AF680 100ul #C27370-AF750 100ul #C27370-Biotin 100ul Description Product Name DFFA Conjugated Antibody Host Species Rabbit Clonality Polyclonal Isotype IgG Purification Affinity purification Applications most applications Species Reactivity Hu,Ms,Rt Immunogen Description Recombinant fusion protein of human DFFA (NP_004392.1). Conjugates Biotin AF350 AF405 AF488 AF555 AF594 AF647 AF680 AF750 Other Names DFFA; DFF-45; DFF1; ICAD; DNA fragmentation factor subunit alpha Accession No. Swiss-Prot#:O00273NCBI Gene ID:1676 Calculated MW 35kDa, 45kDa Formulation 0.01M Sodium Phosphate, 0.25M NaCl, pH 7.6, 5mg/ml Bovine Serum Albumin, 0.02% Sodium Azide Storage Store at 4°C in dark for 6 months Application Details Suggested Dilution: AF350 conjugated: most applications: 1: 50 - 1: 250 AF405 conjugated: most applications: 1: 50 - 1: 250 AF488 conjugated: most applications: 1: 50 - 1: 250 AF555 conjugated: most applications: 1: 50 - 1: 250 AF594 conjugated: most applications: 1: 50 - 1: 250 AF647 conjugated: most applications: 1: 50 - 1: 250 AF680 conjugated: most applications: 1: 50 - 1: 250 AF750 conjugated: most applications: 1: 50 - 1: 250 Biotin conjugated: working with enzyme-conjugated streptavidin, most applications: 1: 50 - 1: 1,000 Background Apoptosis is a cell death process that removes toxic and/or useless cells during mammalian development. The apoptotic process is accompanied by shrinkage and fragmentation of the cells and nuclei and degradation of the chromosomal DNA into nucleosomal units.
    [Show full text]
  • Anti-DFFA Polyclonal Antibody Cat: K001939P Summary
    Anti-DFFA Polyclonal Antibody Cat: K001939P Summary: 【Product name】: Anti-DFFA antibody 【Source】: Rabbit 【Isotype】: IgG 【Species reactivity】: Human Mouse Rat 【Swiss Prot】: O00273 【Gene ID】: 1676 【Calculated】: MW: 29/36kDa 【Observed】: MW: 36kDa 【Purification】: Affinity purification 【Tested applications】: WB IHC IF 【Recommended dilution】: WB 1:500-2000. IHC 1:50-200. IF 1:50-100. 【WB Positive sample】: HepG2 【IHC Positive sample】: Human breast cancer 【Subcellular location】: Cytoplasm. 【Immunogen】: Recombinant protein of human DFFA. 【Storage】: Shipped at 4°C. Upon delivery aliquot and store at -20°C Background: Apoptosis is a cell death process that removes toxic and/or useless cells during mammalian development. The apoptotic process is accompanied by shrinkage and fragmentation of the cells and nuclei and degradation of the chromosomal DNA into nucleosomal units. DNA fragmentation factor (DFF) is a heterodimeric protein of 40-kD (DFFB) and 45-kD (DFFA) subunits. DFFA is the substrate for caspase-3 and triggers DNA fragmentation during apoptosis. DFF becomes activated when DFFA is cleaved by caspase-3. The cleaved fragments of DFFA dissociate from DFFB, the active component of DFF. DFFB has been found to trigger both DNA fragmentation and chromatin condensation during apoptosis. Two alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. Sales:[email protected] For research purposes only. Tech:[email protected] Please visit www.solarbio.com for a more product information Verified picture Western blot analysis with DFFA antibody Immunohistochemistry of paraffin-embedded diluted at 1:1000 Human breast cancer with DFFA antibody diluted at 1:100 Sales:[email protected] For research purposes only.
    [Show full text]
  • Crystal Structure of Human Acinus RNA Recognition Motif Domain
    Crystal structure of human Acinus RNA recognition motif domain Humberto Fernandes1,2,*, Honorata Czapinska1,*, Katarzyna Grudziaz1, Janusz M. Bujnicki1,3 and Martyna Nowacka1,4 1 International Institute of Molecular and Cell Biology in Warsaw, Warsaw, Poland 2 Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland 3 Institute of Molecular Biology and Biotechnology, Faculty of Biology, Adam Mickiewicz University, Poznan, Poland 4 Current Affiliation: University of Warsaw Biological and Chemical Research Centre, Warsaw, Poland * These authors contributed equally to this work. ABSTRACT Acinus is an abundant nuclear protein involved in apoptosis and splicing. It has been implicated in inducing apoptotic chromatin condensation and DNA fragmentation during programmed cell death. Acinus undergoes activation by proteolytic cleavage that produces a truncated p17 form that comprises only the RNA recognition motif (RRM) domain. We have determined the crystal structure of the human Acinus RRM domain (AcRRM) at 1.65 A˚ resolution. It shows a classical four-stranded antiparallel b-sheet fold with two flanking a-helices and an additional, non-classical a-helix at the C-terminus, which harbors the caspase-3 target sequence that is cleaved during Acinus activation. In the structure, the C-terminal a-helix partially occludes the potential ligand binding surface of the b-sheet and hypothetically shields it from non-sequence specific interactions with RNA. Based on the comparison with other RRM-RNA complex structures, it is likely that the C-terminal a-helix changes its conformation with respect to the RRM core in order to enable RNA binding by Acinus. Submitted 18 April 2018 Accepted 14 June 2018 Published 4 July 2018 Subjects Biochemistry, Molecular Biology Corresponding authors Keywords Acinus, Apoptosis, Crystal structure, RRM domain, Splicing factor Janusz M.
    [Show full text]
  • Cddpre6 8 5..5
    Cell Death and Differentiation (1999) 6, 745 ± 752 ã 1999 Stockton Press All rights reserved 13509047/99 $15.00 http://www.stockton-press.co.uk/cdd Structure and promoter analysis of murine CAD and ICAD genes Kohki Kawane1,2, Hidehiro Fukuyama1,2, Masashi Adachi1,2, condensation, and formation of apoptotic bodies,2 and Hideki Sakahira1,2, Neal G. Copeland3, Debra J. Gilbert3, biochemically by degradation of chromosomal DNA into 3 Nancy A. Jenkin3 and Shigekazu Nagata*,1,2 nucleosomal units. Most of the apoptotic stimuli activate caspases, which are cysteine proteases that cleave various 1 Department of Genetics, Osaka University Medical School, Osaka, Japan substrates such as poly(ADP) ribose polymerase, lamin, and 2 Core Research for Evolutional Science and Technology, Japan Science and fodrin to promote the apoptotic process.4±7 We and others Technology Corporation, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan recently showed that a DNase (CAD, caspase-activated 3 Mammalian Genetics Laboratory, ABL-Basic Research Program, National DNase; also called CPAN, caspase activated nuclease, as Cancer Institute-Frederick Cancer Research and Development Center, well as DFF-40, DNA fragmentation factor-40) is activated Frederick, Maryland 21702, USA during apoptosis, and cleaves the chromosomal DNA.8±12 In * corresponding author: Shigekazu Nagata, Ph.D., Department of Genetics, Osaka University Medical School B-3, 2-2 Yamada-oka, Suita, Osaka 565- the growing, non-apoptotic cells, CAD is complexed with its 0871, Japan. inhibitor (ICAD, inhibitor of CAD; also called DFF-45) and tel: 81-6-6879-3310; fax: 81-6-6879-3319; predominantly localized in the cytoplasm.
    [Show full text]